Cari Health, a San Diego, CA-based digital health startup, raised $2.3M in Seed funding.
The round was led by San Diego Angel Conference (SDAC), with participation from NuFund Venture Group, Cove Fund, Chemical Angel Fund, and Medical Devices of Tomorrow, and several individual angel investors.
The company intends to use the funds to expand its intellectual property portfolio, and prepare for the regulatory pathway with the Food and Drug Administration.
Led by Founder and CEO Patrik Schmidle, Cari Health is focused on wearable remote medication monitoring, enabling clinicians to view medication levels in real-time, customize dosages for patients, and keep them on life-saving medications. While the solution can detect a number of medications, the first application will be to enable patients being treated with medications for opioid use disorder (MOUD) to prove treatment compliance remotely, without frequent clinic visits.
The company participated in programs like the Qualcomm Institute Innovation Space, Institute for the Global Entrepreneur MedTech Accelerator program at University of California San Diego, and MedTech Innovator program.